Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.

Key Points Moderna's shares have been southbound for the past few years due to unimpressive financial results. However, progress with the pipeline could significantly boost the stock over the next five years. 10 stocks we like better than Moderna › Long gone are the days when Moderna (NASDAQ: MRNA) would generate over $18 billion in annual sales from its COVID-19 vaccine. Over the past couple of years, the company's revenue and earnings have plummeted along with its stock price. Moderna is eager ...